Zurn Elkay (ZWS) Insider Cuts Stake by 38% in $43 Avg Sale
Rhea-AI Filing Summary
Insider activity: On 31-Jul-2025 Zurn Elkay Water Solutions (ZWS) Chief Information Officer Michael Troutman exercised four vested stock-option tranches—30,871 sh @ $9.69, 37,676 sh @ $11.37, 15,116 sh @ $14.22 and 7,253 sh @ $33.05—acquiring a total of 90,916 common shares.
All 90,916 shares were immediately sold in the open market at a weighted-average $43.01 (range $42.44-$43.39), generating an estimated gross proceed of ≈$3.9 million and eliminating the remaining derivative positions (options balance now 0).
Following the cashless exercise & sale, Troutman’s direct ownership declined to 50,505 shares (from 81,376) plus 1,890 shares held via the 401(k) plan. No additional option awards remain outstanding.
Positive
- Insider retains 52,395 total shares, maintaining some alignment with shareholders.
- Options fully exercised before expiration, eliminating potential overhang from derivative dilution.
Negative
- Immediate sale of 90,916 shares (~$3.9 M) reduces direct ownership by ~38%, a potentially bearish sentiment signal.
- No remaining options may lessen future share-price participation incentives for the CIO.
Insights
TL;DR: CIO exercised expiring options and sold all shares, cutting direct stake by ~38%; modestly negative sentiment signal.
The transaction nets roughly $3.9 million in pre-tax proceeds and clears Troutman’s entire option inventory. While exercising in-the-money options before expiration is typical, the immediate full disposition—leaving only ~52 k shares—suggests limited near-term confidence or personal liquidity needs. Insider selling of this magnitude can pressure sentiment, albeit not necessarily fundamentals. 50 k residual shares still aligns incentives, but reduced exposure may be noted by investors tracking insider trends.
TL;DR: Large insider sale warrants monitoring; governance profile unchanged but optics lean negative.
Rule-compliant Form 4 shows timely disclosure and proper 10b5-1 acknowledgment, mitigating regulatory concern. However, a single-day sale of every share obtained via option exercises can be interpreted as opportunistic profit-taking at multi-year highs. Boards often prefer staggered sales to minimize market impact. Investors should watch for pattern repetition among other executives, which could flag valuation perceptions or upcoming events.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 30,871 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 37,676 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 15,116 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 7,253 | $0.00 | -- |
| Exercise | Common Stock | 30,871 | $9.69 | $299K |
| Exercise | Common Stock | 37,676 | $11.37 | $428K |
| Exercise | Common Stock | 15,116 | $14.22 | $215K |
| Exercise | Common Stock | 7,253 | $33.05 | $240K |
| Sale | Common Stock | 90,916 | $43.01 | $3.91M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes shares acquired under the Company's Employee Stock Purchase Plan in 2025. This transaction was executed in multiple trades at prices ranging from $42.44 to $43.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. Based on information from the trustee of the 401(k) Plan. Option fully vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.
